Tag: Psilera - Psychedelic Alpha

Our 2022 Year in Review is now live.

Psilera’s Award-Winning Co-Founders To Be Featured Speakers at Upcoming Industry Conferences Across the Country.

Post published:October 20, 2022
Post category:Press Release

Psilera Receives First Patent Allowance for Transdermal Patch Formulations

Post published:September 14, 2022
Post category:Press Release

Read more about the article Psilera’s New Compounds Show Potential for Significant Treatment Improvement in Depression and Neurodegenerative Disorders

Psilera’s New Compounds Show Potential for Significant Treatment Improvement in Depression and Neurodegenerative Disorders

Post published:August 10, 2022
Post category:Press Release

Psilera Expands Computational Chemistry Abilities with the Addition of Dr. Daniel N. Santiago

Post published:March 24, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Insights and interviews delivered to your inbox. No spam, just valuable information.

Weekly Bulletin

Your weekly recap of news and analysis from the psychedelic sector.

Research Review

A monthly review of the most important psychedelics research.

News & Interviews

The latest news from across the psychedelics space.

Psychedelics Patent Trackers

We track the latest patents and filings related to psilocybin, MDMA and DMT.

Psychedelic Legalization & Decriminalization Tracker

Mapping psychedelic drug policy reform across the United States

Psychedelics Drug Development Tracker

From drug discovery to regulatory approval, we map drug development in psychedelics.

Stocks & Companies Directory

A directory of all the major psychedelics stocks, companies and ETFs.

Sector Landscape Map

Explore the Psychedelic Sector Landscape visually using our new tool.

Stock Watchlist

A one-stop overview of psychedelics stocks financial performance.

Psilera’s Award-Winning Co-Founders To Be Featured Speakers at Upcoming Industry Conferences Across the Country.

Psilera Receives First Patent Allowance for Transdermal Patch Formulations

Psilera’s New Compounds Show Potential for Significant Treatment Improvement in Depression and Neurodegenerative Disorders

Psilera Expands Computational Chemistry Abilities with the Addition of Dr. Daniel N. Santiago

Psychedelic Alpha

Quick Links

Newsletter

Join Our Newsletter

Psychedelic sector insights, interviews and analysis delivered to your inbox.

No thanks, continue to site.